Skip to main content

and
  1. Article

    Open Access

    Multivalent cytomegalovirus glycoprotein B nucleoside modified mRNA vaccines did not demonstrate a greater antibody breadth

    Human cytomegalovirus (HCMV) remains the most common congenital infection and infectious complication in immunocompromised patients. The most successful HCMV vaccine to date, an HCMV glycoprotein B (gB) subuni...

    Hsuan-Yuan Wang, Leike Li, Cody S. Nelson, Richard Barfield, Sarah Valencia in npj Vaccines (2024)

  2. Article

    Open Access

    Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection

    Human Cytomegalovirus (HCMV) is the leading infectious congenital infection globally and the most common viral infection in transplant recipients, therefore identifying a vaccine for HCMV is a top priority. Hu...

    Sarah M. Valencia, Eric Rochat, Melissa J. Harnois, Maria Dennis in npj Vaccines (2023)

  3. Article

    Open Access

    LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions

    Microglia plays crucial roles in Alzheimer’s disease (AD) development. Triggering receptor expressed on myeloid cells 2 (TREM2) in association with DAP12 mediates signaling affecting microglia function. Here w...

    Peng Zhao, Yuanzhong Xu, Lu-Lin Jiang, Xuejun Fan in Molecular Neurodegeneration (2022)

  4. Article

    Open Access

    A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial

    A conditionally replication-defective human cytomegalovirus (HCMV) vaccine, V160, was shown to be safe and immunogenic in a two-part, double-blind, randomized, placebo-controlled phase I clinical trial (NCT019...

    Leike Li, Daniel C. Freed, Ya** Liu, Fengsheng Li, Diane F. Barrett in npj Vaccines (2021)

  5. No Access

    Article

    LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration

    Immune checkpoint blockade therapy has been successful in treating some types of cancer but has not shown clinical benefits for treating leukaemia1. This result suggests that leukaemia uses unique mechanisms to e...

    Mi Deng, Xun Gui, Jaehyup Kim, Li **e, Weina Chen, Zunling Li, Licai He in Nature (2018)

  6. Article

    Open Access

    Cell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5A

    Hepatitis C virus (HCV) uses components of the very-low-density lipoprotein (VLDL) pathway for assembly/release. We previously reported that hepatocyte nuclear factor 4α (HNF4α) participates in HCV assembly/re...

    Hua Cai, Wenxia Yao, Leike Li, **nlei Li, Longbo Hu, Runming Mai in Scientific Reports (2016)

  7. No Access

    Article

    Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin

    Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1), a type-II Golgi transmembrane protein of unknown function, is up-regulated in many cancers. Its Golgi luminal domain is potentially the major functional domain. The ...

    Yan Zhou, Leike Li, Longbo Hu, Tao Peng in Molecular Biology Reports (2011)